GlassScriptPhysician profile
Elena Shanina
NPI 1699979286
$1,136.89
in general payments reported to CMS, 2019-2025
14 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $31.39 · 2021: $16.82 · 2022: $51.90 · 2023: $238 · 2024: $516 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $892.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $434.12 | 2023-2024 | Botox |
| Genzyme Corporation | $138.46 | 2025 | |
| Ucb, INC. | $134.05 | 2024 | |
| Eisai INC. | $125.00 | 2024 | |
| Emd Serono, INC. | $94.34 | 2019 | |
| Boston Scientific Corporation | $40.46 | 2022-2023 | Bodyguardian |
| Neurocrine Biosciences, INC. | $38.00 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $25.60 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.50 | 2023 | Lifevest |
| Cadwell Industries, INC | $19.36 | 2022 | |
| Amgen INC. | $18.04 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.82 | 2021 | |
| Genentech USA, INC. | $15.01 | 2023 | Evrysdi |
| Pfizer INC. | $12.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elena Shanina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.